PT Enseval Putera Megatrading Terbuka operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Enseval Putera Megatrading Terbuka with three other
drug stores in Asia:
Chuo Bussan Corporation
of Japan
(2011
sales of 130.64 billion Japanese Yen [US$1.28 billion]
of which 99%
was Daily Necessities & Miscellaneous Goods),
Zhejiang International Group Company Limited
of China
(8.53 billion Chinese Renmimbi [US$1.39 billion]
of which 96%
was Sale of Medicines), and
Iwaki & Co., Ltd.
which is
based in Japan
(53.80 billion Japanese Yen [US$526.14 million]
of which 33%
was Pharmaceuticals).
Sales Analysis.
PT Enseval Putera Megatrading Terbuka reported sales of 10.61 trillion Indonesian Rupiahs (US$1.09 billion)
for the
year ending
December of 2011.
This
represents
an
increase of 9.2%
versus 2010, when the company's sales were 9.71 trillion Indonesian Rupiahs.
Sales at PT Enseval Putera Megatrading Terbuka have increased during each of the previous five years
(and since 2006, sales have increased a total of 92%).
Sales of Consumer Products saw an increase
of
15.8% in 2011, from
3.63 trillion Indonesian Rupiahs to 4.20 trillion Indonesian Rupiahs.
Not all segments of PT Enseval Putera Megatrading Terbuka experienced an increase in sales in 2011:
sales of Other fell 5.9% to 1.54 trillion Indonesian Rupiahs.
Business Description